Masonic Cancer Center News
- From basic science to second chances
- If you had met Duane Cramer in the spring of 2008, it would have been hard to guess that he had run out of options for treating his acute myelogenous leukemia. Even after four rounds of the strongest chemotherapy and full-body radiation, the Blaine resident didn’t feel sick.
Fall 2009
- Grant from NIH funds study on chronic graft-versus-host disease
- The National Institutes of Health has awarded a five-year, $9.5 million grant to Bruce Blazar, M.D., of the Masonic Cancer Center, University of Minnesota, and two researchers with Dana-Farber Cancer Institute to further their research on chronic graft-versus-host disease (GVHD).
- CETI: A jump-start for new cancer therapies
-
Promising cancer research often stalls out at the concept level because there’s no funding to complete it. That’s why the Masonic Cancer Center recently created the Cancer Experimental Therapeutics Initiative (CETI).
- Finding answers
- Clark Starr, Ph.D., was two months away from retiring when he and his wife, Jane, got devastating news. Clark had myelodysplasia, a disease in which the bone marrow doesn’t make enough healthy blood cells. It can progress and become acute myelogenous leukemia (AML).
- The science of tobacco control
- President Obama signed the Family Smoking Prevention and Tobacco Control Act, giving the U.S. Food and Drug Administration the power to regulate tobacco products.
- Upcoming events
- PSA: Issues in Screening, Diagnosis, and Treatment (Oct. 29)--Gopher football pre-game reception for breast cancer supporters (Oct. 31)
- What does it mean to be a comprehensive cancer center?
- The National Cancer Institute (NCI) has renewed the Masonic Cancer Center, University of Minnesota’s designation as a comprehensive cancer center for another five years, the longest term possible.
- Center for Prostate Cancer welcomes new leader
- The University of Minnesota welcomed Badrinath R. Konety, M.D., M.B.A., August 31 as director of its Center for Prostate Cancer and head of the Department of Urology. Konety will hold the Endowed Chair in Uro-Oncology.
- Director’s note
- With health-care reform debates happening across the country these days, I can’t help but think of cancer care as a health-care reform issue in many ways.
- New programs address long-term health effects of adult cancer survivors
- Because of advances in detection and treatment, people today often live many years after a cancer diagnosis. And as these survivors live longer, trends in “late effects” of cancer treatment are becoming apparent.
- MCC launches improved clinical trials website
- A new website offers accurate, up-to-date information about more than 250 clinical trials currently available through the Masonic Cancer Center, University of Minnesota.
